Cargando…

Early thromboembolic events in hospitalized COVID-19 patients

Detalles Bibliográficos
Autor principal:	Rosen, Raphael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Letter to the Editors-in-Chief
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7200336/ https://www.ncbi.nlm.nih.gov/pubmed/32403032 http://dx.doi.org/10.1016/j.thromres.2020.05.004

Ejemplares similares

Incidence of venous thromboembolic events in COVID-19 patients after hospital discharge: A systematic review and meta-analysis
por: Zuin, Marco, et al.
Publicado: (2022)

Thromboembolic events related to atrial fibrillation during the COVID-19 epidemic in Denmark
por: Rasmussen, Peter Vibe, et al.
Publicado: (2020)

Reduction of venous thromboembolic events in COVID-19 patients: Which role for IL-6 antagonists?
por: Zuin, Marco, et al.
Publicado: (2021)

Thrombotic complications in critically ill patients with COVID 19
por: Rosen, Raphael J.
Publicado: (2020)

D-dimer cut-off points and risk of venous thromboembolism in adult hospitalized patients with COVID-19
por: Choi, Justin J., et al.
Publicado: (2020)

The pathogenesis of thromboembolic disease in covid-19 patients: Could be a catastrophic antiphospholipid syndrome?
por: Previtali, Giulia, et al.
Publicado: (2020)

Arterial and venous thromboembolic disease in a patient with COVID-19: A case report
por: Brüggemann, Renée, et al.
Publicado: (2020)

Bacterial surinfection and venous thromboembolism in critically ill ICU patients with COVID-19: What is the relationship?
por: Stessel, Björn, et al.
Publicado: (2021)

In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis
por: Mumoli, Nicola, et al.
Publicado: (2021)

Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19
por: Zermatten, Maxime G., et al.
Publicado: (2020)

No evidence of increased rate of thrombotic recurrences in patients with history of venous thromboembolism after vaccination for COVID-19
por: Porfidia, Angelo, et al.
Publicado: (2022)

Extensive pulmonary perfusion defects compatible with microthrombosis and thromboembolic disease in severe Covid-19 pneumonia
por: Beenen, L.F.M., et al.
Publicado: (2020)

Updated hospital associated venous thromboembolism outcomes with 90-days follow-up after hospitalisation for severe COVID-19 in two UK critical care units
por: Doyle, Andrew J., et al.
Publicado: (2020)

COVID-19 associated Venous Thromboembolism (VTE) burden in Black women: Findings of Veterans Affairs COVID-19 Shared Data
por: Choi, Sung-Hee, et al.
Publicado: (2022)

The effect of race on composite thrombotic events in patients with COVID-19
por: Esenwa, Charles, et al.
Publicado: (2021)

Incidence of venous and arterial thromboembolic complications in COVID-19: A systematic review and meta-analysis
por: Kunutsor, Setor K., et al.
Publicado: (2020)

Utility of D-dimer in predicting venous thromboembolism in non-mechanically ventilated COVID-19 survivors()
por: Nauka, Peter C., et al.
Publicado: (2021)

Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study
por: Godon, Alexandre, et al.
Publicado: (2021)

Covid-19 vaccination, adverse events, and detection of antibodies
por: Kristensen, Søren Risom, et al.
Publicado: (2021)

Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia
por: Hsu, Andrew, et al.
Publicado: (2020)

Delayed catastrophic thrombotic events in post-acute COVID-19
por: Gupta, Abhinav, et al.
Publicado: (2022)

Comparison of IMPROVE, modified IMPROVE, IMPROVEDD, Padua and CHA2DS2-VASC risk scores for venous and arterial thrombotic events prediction in hospitalized COVID-19 patients
por: Lucijanic, Marko, et al.
Publicado: (2022)

Major cardiovascular events after COVID-19, event rates post-vaccination, antiviral or anti-inflammatory therapy, and temporal trends: Correspondence
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Incidence of thrombotic outcomes for patients hospitalized and discharged after COVID-19 infection
por: Bourguignon, Alex, et al.
Publicado: (2020)

Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom
por: Thomas, W., et al.
Publicado: (2020)

Managing suspected venous thromboembolism when a pandemic limits diagnostic testing
por: Schaefer, Jordan K., et al.
Publicado: (2020)

D-dimer driven deep vein thrombosis prophylaxis strategy for hospitalized patients with COVID-19
por: Stawiarski, Kristin, et al.
Publicado: (2021)

Thromboprophylaxis in COVID-19: Early initiation might be as important as optimal dosing
por: Kollias, Anastasios, et al.
Publicado: (2021)

Pre-admission anticoagulant therapy and mortality in hospitalized COVID-19 patients: A retrospective cohort study
por: van Haaps, Thijs F., et al.
Publicado: (2021)

Venous thromboembolism and coronavirus disease 2019 in an ambulatory care setting - A report of 4 cases
por: Overstad, Siri, et al.
Publicado: (2020)

Therapeutic anticoagulation in COVID-19 patients
por: Belfaqeeh, O., et al.
Publicado: (2021)

Low admission protein C levels are a risk factor for disease worsening and mortality in hospitalized patients with COVID-19
por: Stanne, Tara M., et al.
Publicado: (2021)

COVID-19 coagulopathy and thrombosis: Analysis of hospital protocols in response to the rapidly evolving pandemic
por: Parks, Anna L., et al.
Publicado: (2020)

Hospitalizations, resource use and outcomes of acute pulmonary embolism in Germany during the Covid-19 pandemic
por: Husser, Daniela, et al.
Publicado: (2021)

Therapeutic anticoagulation in COVID-19 patients
por: Lemos, Anna Cristina Bertoldi, et al.
Publicado: (2021)

Portal vein thrombosis in a patient with COVID-19
por: Franco-Moreno, A., et al.
Publicado: (2020)

Rotational thromboelastometry to assess hypercoagulability in COVID-19 patients
por: van Veenendaal, Nadine, et al.
Publicado: (2020)

Early effects of unfractionated heparin on clinical and radiological signs and D-dimer levels in patients with COVID-19 associated pulmonary embolism: An observational cohort study
Publicado: (2021)

Heparin-induced thrombocytopenia and thrombosis in a patient with Covid-19()
por: Huang, Ching-Tai, et al.
Publicado: (2020)

Increased prevalence of heparin induced thrombocytopenia in COVID-19 patients
por: Preti, Paola S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_16m6230nnj634ge150avdt63qc